Publications by EPC Staff
Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis. Clinical Interventions in Aging 2008; 3(2):1-15.
Hansen RA, Gaynes BN, Gartlehner G, Moore CG, Tiwari R, Lohr KN. Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. International Clinical Psychopharmacology 2008; 23(3):170-9.
Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clinical Rheumatology 2008, 27(1):67-76.
Hansen RA, Gartlehner G, Lohr KN, Kaufer DI. Functional outcomes of drug treatment in Alzheimer’s disease: A systematic review and meta-analysis. Drugs and Aging 2007; 24(2):155-167.
Gartlehner G, Hansen RA, Jonas B, Thieda T, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and meta-analysis. The Journal of Rheumatology. 2006;33(12):1-11.
Peterson K, McDonagh MS, Fu R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology. 2008;197(1);1-11.
Carson S, McDonagh M, Peterson K. "A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia," Journal of the American Geriatric Society. 54 (2006): 354-361.
Chou R. Peterson K. Helfand M. "Comparative Efficacy and Safety of Skeletal Muscle Relaxants for Spasticity and Musculoskeletal Conditions: A Systematic Review,". Journal of Pain & Symptom Management. 28(2) (2004) :140-75.
Gartlehner, G. et al, "Discontinuation Risk for Selective Serotonin Reuptake Inhibitors and Other Second Generation Antidepressants in Outpatients with Major Depressive Disorder: A Systematic Review and Meta-analysis,". International Clinical Psychopharmacology. 20 (2005): 59-69.
Gartlehner, G., et al, "Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes,". Annals of Family Medicine. 4(2) (200): 253-262.
Hansen, RA et al, "Efficacy and Safety of Second-generation Antidepressants in the Treatment of Major Depressive Disorders," Annals of Internal Medicine. 143, (2005) :415-426.
Publications by Center for Evidence-based Policy Staff
Santa, John, Gibson, Mark. "Designing Benefits with Evidence in Mind,". ERPI Issue Brief, No. 290, February 2006. Available at SSRN: http//ssrn.com/abstract=887311.
Santa, John. "Lessons from Oregon: Changing the Way Health Care Works," Open Spaces. 8(1), (2005) 22-28.
Hoadley J, Crowley J, Bergman D, Kaye N. "Understanding Key Features of the Drug Effectiveness Review Project (DERP) and Lessons for State Policy Makers," NASHP Issue Brief, March 2006. Available at: http://www.nashp.org/node/812
"Washington State: An Integrated Approach to Evidence-based Drug Purchasing", The Commonwealth Fund Newsletter, available at http://www.cmwf.org/publications
"A State Collaboration: Incorporating Evidence into Medicaid Decision-Making", The Commonwealth Fund Newsletter, available at http://www.cmwf.org/publications